{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-082250","form_type":"8-K","ticker":"TRAW","cik":"0001130598","company_name":"Traws Pharma, Inc.","filed_at":"2026-07-09T20:01:22+00:00","discovered_at":"2026-07-09T20:02:00.652907+00:00","generated_at":"2026-07-09T20:02:07.495741+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Traws Pharma shareholders approve 2M share increase in incentive plan and warrant issuance at annual meeting","bullets":["Stockholders approved amendment to 2021 Incentive Compensation Plan, increasing authorized shares by 2,000,000 (4,821,796 for, 1,694,075 against).","Proposal 4 approved issuance of shares upon exercise of Series B and C Warrants issued under April 15, 2026 Securities Purchase Agreement (2,270,414 for, 151,196 against).","All seven director nominees elected; KPMG ratified as auditor for FY 2026 (7,659,805 for).","Certain shares (3,486,423) excluded from voting on Proposal 4 per Nasdaq rules; total outstanding shares 15,150,669 as of May 18, 2026 record date."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-082250","json":"https://secwatch.observer/filing/0001104659-26-082250.json","markdown":"https://secwatch.observer/filing/0001104659-26-082250.md","text":"https://secwatch.observer/filing/0001104659-26-082250.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130598/000110465926082250/0001104659-26-082250-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130598/000110465926082250/tm2620113d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-09T20:02:07.495741+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}